High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in I (Q56762440)
Jump to navigation
Jump to search
scientific article published on 31 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in I |
scientific article published on 31 January 2015 |
Statements
High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran (English)
Maryam Rouhani
Sedigheh Zakeri
Sakineh Pirahmadi
Ahmad Raeisi
Navid Dinparast Djadid
31 January 2015